Jean Jacques Bienaime - 24 Mar 2025 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
24 Mar 2025
Net transactions value
+$57,470
Form type
4
Filing time
25 Mar 2025, 17:18:02 UTC
Previous filing
19 Aug 2024
Next filing
26 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Purchase $57,470 +7,000 +42% $8.21 23,615 24 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction report was $8.21, and the range of prices were between $8.16 and $8.42, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.